Overview

Repurposing Low-Dose Clonidine for PTSD in Veterans

Status:
Not yet recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
Hypothesis: Veterans with PTSD prescribed clonidine will demonstrate improvements in PTSD symptoms, including daytime, nighttime, and sleep-related behaviors.
Phase:
Phase 3
Details
Lead Sponsor:
Aurora Health Care
Treatments:
Clonidine